The 1000 Genomes Project announced that three companies involved in the development of new sequencing instrumentation have joined an international effort to build a detailed map of human genetic variation for medical research.
The 1000 Genomes Project announced that three companies involved in the development of new sequencing instrumentation have joined an international effort to build a detailed map of human genetic variation for medical research. The new participants are 454 Life Sciences, a Roche company (Branford, Connecticut); Applied Biosystems, an Applera Corp. business (Foster City, California); and Illumina Inc. (San Diego, California). The 1000 Genomes Project is an international research consortium formed in January 2008 with a goal of creating a new map of the human genome to show biomedically relevant DNA variations at a higher resolution than current techniques.
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.